Characterizing QT interval prolongation in early clinical development: a case study with methadone

od Dubois, Vincent F. S., Danhof, Meindert, Della Pasqua, Oscar
Izdano u Pharmacol Res Perspect (2017)

Model-based evaluation of drug-induced QTc prolongation for compounds in early development

od Dubois, Vincent F S, Yu, Huixin, Danhof, Meindert, Della Pasqua, Oscar
Izdano u Br J Clin Pharmacol (2015)

Translating QT interval prolongation from conscious dogs to humans

od Dubois, Vincent F. S., Smania, Giovanni, Yu, Huixin, Graf, Ramona, Chain, Anne S. Y., Danhof, Meindert, Della Pasqua, Oscar
Izdano u Br J Clin Pharmacol (2016)

Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapy

od González‐García, Ignacio, Pierre, Vadryn, Dubois, Vincent F. S., Morsli, Nassim, Spencer, Stuart, Baverel, Paul G., Moore, Helen
Izdano u CPT Pharmacometrics Syst Pharmacol (2021)

Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as Total

od Hood, John, González-García, Ignacio, White, Nicholas, Marshall, Leeron, Dubois, Vincent F. S., Vicini, Paolo, Baverel, Paul G.
Izdano u Pharmaceutics (2021)

Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status

od Baverel, Paul G., Dubois, Vincent F.S., Jin, Chao Yu, Zheng, Yanan, Song, Xuyang, Jin, Xiaoping, Mukhopadhyay, Pralay, Gupta, Ashok, Dennis, Phillip A., Ben, Yong, Vicini, Paolo, Roskos, Lorin, Narwal, Rajesh
Izdano u Clin Pharmacol Ther (2018)